SYNTEIN
LIVE

Serial Number

98248592

Owner

Abiologics, Inc.

Attorney

Christina Licursi

Filing Date

Oct 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SYNTEIN Trademark

Serial Number: 98248592

SYNTEIN is a trademark filed by Abiologics, Inc. on October 31, 2023. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Abiologics, Inc.

One Kendall Square
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

October 31, 2023

Registration Date

Not Registered

Published for Opposition

October 15, 2024

Goods & Services

Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use

Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptides

Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2026 EXRA
SOU EXTENSION 3 GRANTED
May 13, 2026 EX3G
SOU EXTENSION 3 FILED
May 13, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
May 13, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 5, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 5, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 22, 2025 EX1G
SOU EXTENSION 1 FILED
May 22, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 22, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Nov 25, 2024 CHPB
ASSIGNED TO PETITION STAFF
Nov 18, 2024 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 24, 2024 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 18, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 13, 2023 NWOS